Aspirin 75mg dispersible tablets

Țară: Regatul Unit

Limbă: engleză

Sursă: MHRA (Medicines & Healthcare Products Regulatory Agency)

Ingredient activ:

Aspirin

Disponibil de la:

Thornton & Ross Ltd

Codul ATC:

B01AC06

INN (nume internaţional):

Aspirin

Dozare:

75mg

Forma farmaceutică:

Dispersible tablet

Calea de administrare:

Oral

Clasă:

No Controlled Drug Status

Tip de prescriptie medicala:

Valid as a prescribable product

Rezumat produs:

BNF: 02090000

Caracteristicilor produsului

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Dispersible Aspirin Tablets BP 75mg
Dispersible Aspirin 75mg Tablets
POST MI® 75mg Dispersible Tablets
Boots Aspirin 75mg Dispersible tablets
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Aspirin BP 75.0mg
3.
PHARMACEUTICAL FORM
Dispersible tablets
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
For the secondary prevention of thrombotic cerebrovascular or
cardiovascular disease
and following by-pass surgery.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
The advice of a doctor should be sought before commencing therapy for
the first time.
The usual dosage, for long term use, is 75-150mg daily. In some
circumstances, a
higher dose may be appropriate, especially in the short term, and up
to 300mg a day
may be used on the advice of a doctor.
_Children: _Do not give to children aged under 16 years, unless
specifically indicated
(e.g. for Kawasaki’s disease).
4.3
CONTRAINDICATIONS
Aspirin is contraindicated in patients with;
•
active peptic ulceration or a history of peptic ulceration.
•
Haemophilia, haemorrhagic disease or a history of bleeding disorders.
•
Gout or a history of gout.
•
Hypersensitivity to aspirin (e.g. asthma, rhinitis, angioedema or
urticaria),
other NSAIDs or other tablet excipients
•
During the third trimester of pregnancy
•
children under 16 (except for the treatment of Still’s disease),
•
breast feeding,.
•
concurrent anticoagulant therapy.
4.4
SPECIAL WARNINGS AND PRECAUTIONS FOR USE
Before commencing long term aspirin therapy, for the management of
cardiovascular
and cerebrovascular disease, patients should consult their
doctor who can advise on the relative benefits versus the risks for
the
individual patient.
Administer with caution in the presence of renal or hepatic
impairment, dehydration.
There is a possible association between aspirin and Reye’s syndrome
when given to children.
Reye’s syndrome is a very rare disease, which affects the brain and
liver and can be fatal. For
this reason aspirin should n